 Pharmaceutical Preparations
"Pharmaceutical Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
| Descriptor ID |
D004364
|
| MeSH Number(s) |
D26
|
| Concept/Terms |
Pharmaceutical Preparations- Pharmaceutical Preparations
- Pharmaceutic Preparations
- Preparations, Pharmaceutic
- Preparations, Pharmaceutical
- Drugs
- Pharmaceutical Products
- Products, Pharmaceutical
|
Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Preparations".
Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Preparations".
This graph shows the total number of publications written about "Pharmaceutical Preparations" by people in this website by year, and whether "Pharmaceutical Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 5 | 1 | 6 | | 2005 | 4 | 0 | 4 | | 2006 | 4 | 1 | 5 | | 2007 | 3 | 1 | 4 | | 2008 | 1 | 5 | 6 | | 2009 | 4 | 0 | 4 | | 2010 | 6 | 0 | 6 | | 2011 | 2 | 1 | 3 | | 2012 | 4 | 1 | 5 | | 2013 | 3 | 2 | 5 | | 2014 | 5 | 1 | 6 | | 2015 | 6 | 1 | 7 | | 2016 | 5 | 1 | 6 | | 2017 | 1 | 2 | 3 | | 2018 | 4 | 4 | 8 | | 2019 | 2 | 1 | 3 | | 2020 | 16 | 2 | 18 | | 2021 | 16 | 1 | 17 | | 2022 | 1 | 11 | 12 | | 2023 | 2 | 5 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmaceutical Preparations" by people in Profiles.
-
Toyserkani GA, Ewusie SB, Turk P, Quick J, Morrato EH. Evolution of Cross-Sectional Survey Protocol Quality Over Time: A Case Series of Index U.S. REMS Knowledge Survey Protocols (2007-2020). Drug Saf. 2023 11; 46(11):1073-1087.
-
Leonhardt MM, Spartz JR, Shankar A, Murphy SA. Fatal drug use in the COVID-19 pandemic response: Changing trends in drug-involved deaths before and after stay-at-home orders in Louisiana. Front Public Health. 2023; 11:1117841.
-
Antoon JW, Feinstein JA, Goldman JL, Kyler KE, Shah SS. Advancing pediatric medication safety using real-world data: Current problems and potential solutions. J Hosp Med. 2023 09; 18(9):865-869.
-
DiStefano MJ, Markell JM, Doherty CC, Alexander GC, Anderson GF. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising. JAMA. 2023 02 07; 329(5):386-392.
-
Gibbons JB, Laber M, Bennett CL. Humira: the first $20 billion drug. Am J Manag Care. 2023 02; 29(2):78-80.
-
MacLaren R. Considerations when administering medications enterally in the critically ill. Curr Opin Clin Nutr Metab Care. 2023 05 01; 26(3):302-306.
-
Naseri K, Kiani Z, Sajadi ZS, Mehrpour O, Javadmoosavi SY, Forouzanfar F, Sadeghi M. Pharmaceutical toxicity is a common pattern of inpatient acute poisonings in Birjand City, East of Iran. Sci Rep. 2023 01 24; 13(1):1312.
-
Ross EL, Petty K, Salinas A, Her C, Carpenter JF. Physical compatibility of medications with concentrated neonatal and pediatric parenteral nutrition: A simulated Y-site drug compatibility study. JPEN J Parenter Enteral Nutr. 2023 03; 47(3):372-381.
-
Dedrick RM, Smith BE, Cristinziano M, Freeman KG, Jacobs-Sera D, Belessis Y, Whitney Brown A, Cohen KA, Davidson RM, van Duin D, Gainey A, Garcia CB, Robert George CR, Haidar G, Ip W, Iredell J, Khatami A, Little JS, Malmivaara K, McMullan BJ, Michalik DE, Moscatelli A, Nick JA, Tupayachi Ortiz MG, Polenakovik HM, Robinson PD, Skurnik M, Solomon DA, Soothill J, Spencer H, Wark P, Worth A, Schooley RT, Benson CA, Hatfull GF. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease. Clin Infect Dis. 2023 01 06; 76(1):103-112.
-
Patel S, Qualls J, Pinnell D, Rathod A, Chen W, Sauer BC. Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system. J Manag Care Spec Pharm. 2022 Dec; 28(12):1410-1418.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|